Gensei

Gensei is a biotechnology company focused on the discovery and development of novel therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes a proprietary yeast-based platform that enables the functional expression and high-throughput screening of human GPCRs in a simplified cellular environment. This technology aims to overcome traditional challenges in GPCR drug discovery, such as receptor stability and signaling complexity, to identify high-affinity small molecule candidates. Gensei's research primarily targets metabolic, neurological, and inflammatory conditions where GPCR signaling plays a critical role in disease pathology.